KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Idexx Laboratories (IDXX) Treasury Shares (2016 - 2026)

Idexx Laboratories has reported Treasury Shares over the past 17 years, most recently at $6.6 billion for Q4 2025.

  • For Q4 2025, Treasury Shares rose 23.01% year-over-year to $6.6 billion; the TTM value through Dec 2025 reached $6.6 billion, up 23.01%, while the annual FY2025 figure was $6.6 billion, 23.01% up from the prior year.
  • Treasury Shares for Q4 2025 was $2.4 million at Idexx Laboratories, up from $411000.0 in the prior quarter.
  • Over five years, Treasury Shares peaked at $27.9 million in Q2 2025 and troughed at $175000.0 in Q4 2023.
  • A 5-year average of $12.8 million and a median of $11.9 million in 2021 define the central range for Treasury Shares.
  • Biggest five-year swings in Treasury Shares: surged 32.3% in 2022 and later grew 1.88% in 2023.
  • Year by year, Treasury Shares stood at $3.6 billion in 2021, then grew by 23.0% to $4.4 billion in 2022, then grew by 1.88% to $4.5 billion in 2023, then rose by 19.2% to $5.3 billion in 2024, then grew by 23.01% to $6.6 billion in 2025.
  • Business Quant data shows Treasury Shares for IDXX at $6.6 billion in Q4 2025, $6.3 billion in Q3 2025, and $6.1 billion in Q2 2025.